[Circadian variations in the onset of acute myocardial infarction]

M Trappolini1, S Matteoli, M C Borgia

  • 1Policlinico Umberto I, Dipartimento di Scienze Cliniche, Università degli Studi La Sapienza, Rome, Italy.

Minerva Cardioangiologica
|September 5, 2001
PubMed

Insights

Acute myocardial infarction (AMI) shows a morning peak incidence, particularly in men and smokers. This circadian pattern is absent in diabetics and hypertensives, with higher mortality for nighttime AMIs.

Area of Science:

  • Cardiology
  • Chronobiology
  • Epidemiology

Context:

  • Circadian patterns in acute myocardial infarction (AMI) onset are established, with a known morning peak.
  • Variations in these rhythms across patient subgroups are suspected but not fully elucidated.

Purpose:

  • To investigate whether the circadian incidence of AMI differs based on sex, age, cardiovascular risk factors, prior ischemic events, AMI location, and short-term outcomes.
  • To identify specific patient subgroups exhibiting distinct circadian patterns in AMI onset.

Summary:

  • A significant peak incidence of AMI occurred between 6:01 AM and 12:00 PM (32.4%).
  • This morning peak was observed in patients aged 65+, men, smokers, and those with/without hypercholesterolemia.
  • Circadian rhythmicity was absent in diabetics, hypertensives, and those with previous cardiovascular events. Inferior AMI showed a morning peak, unlike anterior or non-Q wave AMI.
  • Mortality was higher for AMIs with onset during nighttime hours.

Impact:

  • Provides insights into chronobiological factors influencing AMI, particularly morning triggers.
  • Highlights the need for tailored preventive strategies and treatment approaches considering patient-specific circadian rhythms.
  • Informs clinical practice regarding the timing of interventions and risk management for acute myocardial infarction.
Abstract

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...